Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer
- 25 August 2006
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (5), 483-486
- https://doi.org/10.1136/jcp.2005.033407
Abstract
Aim: To investigate whether nuclear and cytoplasmic Maspin expression is associated with distinct clinicopathological parameters and TP53 expression in a representative series of primary non-small cell lung cancer (NSCLC). Methods: Tissue microarrays (n = 487) were used to immunohistochemically analyse expression of Maspin and TP53. Cytoplasmic and nuclear expression of Maspin was scored on the basis of the percentage of positive tumour cells. Univariate analysis of clinicopathological variables potentially affecting tumour-specific survival was performed. Results: Immunohistochemical Maspin expression (nuclear and cytoplasmic) was informative in 72.3% (352/487) of cases. Cytoplasmic and nuclear Maspin immunoreactivity in ⩾10% of tumour cells was detected in 37.8% (133/352) and 65.3% (230/352) of informative cases, respectively. Nuclear and cytoplasmic Maspin staining was observed more frequently in primary squamous cell carcinomas than in other lung cancer types. Only nuclear Maspin immunoreactivity was significantly associated with positive TP53 staining. Cytoplasmic or nuclear Maspin expression was not associated with tumour-specific survival. Conclusion: Maspin expression was found both in the nucleus and the cytoplasm of NSCLC, more frequently in squamous cell carcinomas. However, no association with tumour-specific survival could be demonstrated.Keywords
This publication has 25 references indexed in Scilit:
- Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung CancerThe Annals of Thoracic Surgery, 2005
- Maspin expression in normal skin and usual cutaneous carcinomasVirchows Archiv A Pathological Anatomy and Histopathology, 2002
- Expression profiling of primary non-small cell lung cancer for target identificationOncogene, 2002
- Expression and Regulation of Tumor Suppressor Gene Maspin in Breast CancerClinical Breast Cancer, 2002
- The paradoxical expression of maspin in ovarian carcinoma.2002
- Expression of maspin predicts poor prognosis in breast‐cancer patientsInternational Journal of Cancer, 2002
- Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.2002
- Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissuesCancer Letters, 2001
- Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studiesThe Journal of Pathology, 2001
- p53 Regulates the Expression of the Tumor Suppressor Gene MaspinOnline Journal of Public Health Informatics, 2000